CymitQuimica logo

CAS 943962-47-8

:

BMS303141

Description:
BMS303141, with the CAS number 943962-47-8, is a chemical compound that has been studied primarily for its potential therapeutic applications, particularly in the field of oncology. It is classified as a small molecule inhibitor, specifically targeting certain pathways involved in cancer cell proliferation and survival. The compound exhibits a specific mechanism of action that disrupts the signaling pathways essential for tumor growth, making it a candidate for cancer treatment. In terms of its physical and chemical properties, BMS303141 is typically characterized by its molecular structure, which includes various functional groups that contribute to its biological activity. The compound's solubility, stability, and reactivity are also important factors that influence its efficacy and safety profile in clinical settings. As research continues, further insights into its pharmacokinetics, pharmacodynamics, and potential side effects are being explored to better understand its role in cancer therapy.
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
  • BMS 303141

    CAS:
    Formula:C19H15Cl2NO4S
    Purity:98%
    Color and Shape:Solid
    Molecular weight:424.2977

    Ref: IN-DA01DOPW

    1mg
    52.00€
    5mg
    121.00€
    10mg
    164.00€
    25mg
    270.00€
    50mg
    495.00€
    100mg
    To inquire
    200mg
    To inquire
  • BMS-303141

    CAS:
    BMS-303141
    Purity:≥98%
    Molecular weight:424.3g/mol

    Ref: 54-BUP09815

    5mg
    96.00€
    10mg
    120.00€
    25mg
    204.00€
    50mg
    382.00€
    100mg
    589.00€
    500mg
    1,181.00€
  • BMS-303141

    CAS:
    BMS-303141 is a potent ATP-citrate lyase (ACL) inhibitor (IC50: 0.13 uM, human recombinant ACL).
    Formula:C19H15Cl2NO4S
    Purity:98% - 99.47%
    Color and Shape:Solid
    Molecular weight:424.3
  • BMS-303141

    CAS:
    <p>BMS-303141 is a fatty acid that inhibits the uptake of iron by macrophages and may have therapeutic potential for the treatment of metabolic disorders, autoimmune diseases, and muscle diseases. BMS-303141 has been shown to inhibit autophagy in prostate cancer cells in vitro and to reduce hepcidin expression. Autophagy is an important process for maintaining cellular homeostasis. It involves the degradation of cytoplasmic components through lysosomes, which are membrane-bound structures found in most animal cells. Autophagy is activated during periods of starvation or when the cell is infected with a virus or bacterium and needs to eliminate the intracellular pathogen. Hepcidin is a hormone produced by the liver that regulates iron homeostasis by inhibiting erythropoiesis (the production of red blood cells) and mobilizing iron stores from macrophages into circulation.</p>
    Formula:C19H15Cl2NO4S
    Purity:Min. 95%
    Molecular weight:424.3 g/mol

    Ref: 3D-TMB96247

    50mg
    917.00€
    100mg
    1,203.00€